June 23, 2008

FUNDING OPPORTUNITY–Junior Investigators: Case CCC ACS IRG

The Case Comprehensive Cancer Center is currently accepting applications for it's American Cancer Society Institutional Research Grant. Pilot funding is available for projects in basic, clinical, behavioral, and epidemiological cancer research with awards up to $30,000 for 1 year cancer research projects that provide the basis for future independent grants.

Eligible applicants must:
–be within 6 years of their first full-time independent faculty appointment (or equivalent);
–be United States citizens, noncitizen nationals, or permanent residents of the United States;
–be eligible to apply as principal investigators for national grant support, but have no such support at the time of the IRG award;
–have Department Chair commitment for salary and space.

Deadline: August 11

To view application and instructions, please click here.

ASCO-NCI-European Organization for Research and Treatment of Cancer (EORTC) Diagnostic Tutorial

October 29-30, 2008
Hollywood, FL

The American Society of Clinical Oncology (ASCO) is accepting applications for grants related to the upcoming ASCO-NCI-European Organization for Research and Treatment of Cancer (EORTC) Diagnostic Tutorial to be held October 29-30 in Hollywood, Florida. The Diagnostic Development Tutorial is designed for faculty members in early development to provide them with tools to translate new biomarkers into clinical trials. A total of 25 trainees will be provided grants to attend this tutorial.

A letter from your director is required to apply. If you are interested in attending this tutorial, please contact Dr. Stanton Gerson stanton.gerson@case.edu.

Application Deadline: August 15

For application information, please click here.

MOLECULAR CANCER THERAPEUTICS ARTICLE- Danielpour and Garcia

Congratulations to Cancer Center Members, Jorge A. Garcia, MD and David Danielpour, PhD, for their article, "Mammalian Target of Rapamycin Inhibition as a Therapeutic Strategy in the Management of Urologic Malignancies", which was printed in the June 1, 2008 issue of Molecular Cancer Therapeutics. To view the article, please click here.

FUNDING OPPORTUNIY– National Lung Cancer Partnership/The LUNGevity Foundation

The National Lung Cancer Partnership/The LUNGevity Foundation are currently accepting applications for the 2008 Research Grant Program. The purpose of this Grant Program is to drive research forward that will increase understanding of lung cancer risk, biology, and response to treatment. National Lung Cancer Partnership and the LUNGevity Foundation are particularly interested in research that will aid in prevention, detection, diagnosis, screening, treatment, and symptom management of lung cancer. Two grants are available: one grant is available specifically for research in the area of sex differences in lung cancer; one grant is available for research pertaining to any facet of lung cancer.

Deadline: September 2

For more information, please click here.

DR. OTIS W. BRAWLEY– Pfizer Visiting Professor in Oncology

We are pleased to welcome Otis W. Brawley, MD as the Pfizer Visiting Professor in Oncology. In connection with the professorship, Dr. Brawley will be giving several talks in Cleveland June 23-25, 2008. Dr. Brawley is a leader in health disparities research, and has spent much time highlighting the social and economic factors which create healthcare disparities in cancer care. Dr. Brawley's visit was made possible by a Pfizer Medical and Academic Partnerships (MAP) Grant.

Dr. Brawley is currently the Chief Medical Officer at the American Cancer Society. He attended the University of Chicago for his undergraduate degree as well as for medical school. Dr. Brawley was an intern and subsequently a resident at University Hospital of Cleveland, Case Western Reserve University. He was also a Medical Staff Fellow in the Division of Cancer Treatment at the National Cancer Institute.

Please mark your calendars for the following seminars featuring Dr. Brawley:

June 23
(Special) David Satcher Lecture
Topic: Highlighting Issues with Cancer in Underserved Populations
11:45 am - 1:00 pm Kulas Auditorium (Lakeside 5th Floor)
Lunch will be served

June 23
Town Hall Meeting
Topic: Opening New Doors in Cancer Communication in the 21st Century
6:00 pm - 8:00 pm Karamu House, 2355 East 89th Street, Cleveland
Refreshments will be served
For more information or to RSVP, call (216)844-5176, or email cmr4@case.edu

June 25
Grand Rounds
Topic: Health Policy and Cancer Care Disparities
8:00 am - 9:00 am Lerner B-181

CASE CCC RETREAT

The 2008 scientific retreat of the Cancer Center will be July 11-12 at Sawmill Creek Resort and Conference Center in Huron, Ohio. This annual gathering is an important event for the Cancer Center, as it gives us the opportunity to evaluate our current initiatives and adjust our development and scientific priorities as needed. To view the agenda, please click here.

Please fill out the Registration Form and let us know whether or not you are able to attend. Please return the form to Gillian Irwin (gillian.irwin@case.edu or fax 844-7832) as soon as possible.

EVENTS

**All events are open to anyone interested in attending

June 23

Special David Satcher Lecture
Otis Brawley, MD
Chief Medical Officer
American Cancer Society
Pfizer Visiting Professor in Oncology
Topic: Highlighting Issues with Cancer in Underserved Populations
11:45 am - 1:00 pm Kulas Auditorium (Lakeside 5th Floor)

Cancer Genetics/ Biology Journal Club
Alina Bulgar
Graduate Student, Gerson Lab, Div. of Hem/Onc
CWRU/ UH
Topic: Impact of Base Excision Repair on Fludarabine Action: Identifying New Therapeutic Strategy
12:00 pm WRB 2-136 Conference Room

Physiology & Biophysics Seminar
Joseph LaManna, PhD
Professor, Anatomy
CWRU
Topic: Brain Angioplasticity: Micovascular Remodeling in the Mature Rodent Brain
4:00 pm SOM W428

Town Hall Meeting
Otis Brawley, MD
Chief Medical Officer
American Cancer Society
Pfizer Visiting Professor in Oncology
Topic: Opening New Doors in Cancer Communication in the 21st Century
6:00 pm - 8:00 pm Karamu House, 2355 East 89th Street, Cleveland
Please RSVP to cmr4@case.edu

June 24

Affymetrix Seminar
James Mellott
Affymetrix Genomics Specialist
AND
Kevin Breitbach
Affymetrix FAS
Topic: The Value of Integrated Approaches to Cancer Studies: Combining DNA Copy Number and Gene Expression for a Comprehensive View of the Cancer Genome
AND
Matthias Kretzler, MD
Associate Professor, Internal Medicine
University of Michigan
Topic: Integrative Genomics of Diabetic Nephropathy: Linking Gene Expression Profiles with Genome Wide Association Studies
10:30 am - 1:30 pm WRB 1413
Register

June 25

Grand Rounds
Otis Brawley, MD
Chief Medical Officer
American Cancer Society
Pfizer Visiting Professor in Oncology
Topic: Health Policy and Cancer Care Disparities
8:00 am Lerner B-151

June 26

Biochemistry Faculty Candidate Seminar
Anyong Xie, MD
Department of Medicine
Beth Israel Deaconess Medical Center & Harvard Medical School
Topic: Engaging a Pathway: Role of the Chromatin Response in Mammalian DNA Double Strand Break Repair
3:30 pm SOM W428

June 27

Hematology/Oncology Fellows Seminar cancelled- Congratulations to the new graduates!

Cancer Center Seminar Series/ Blood Club will resume in the Fall

Taussig Cancer Center Grand Rounds cancelled

ASCO Review 2008
June 27
InterContinental Hotel & Bank of America Conference Center
Course Directors: Robert Dreicer, MD and Hillard Lazarus, MD
Brochure and Registration

more

For a complete listing of LRI seminars click here.

MARK YOUR CALENDARS:

UPCOMING CANCER CENTER SYMPOSIUMS

**For more information on these symposiums, please contact Christine Rhoads.

Head and Neck Conference
April 17, 2009
Holiday Inn, Independence
Details to follow

Faculty Positions Available – K12 Clinical Oncology Research Career Development Award

The Case Comprehensive Cancer Center is accepting applications for its K12 Clinical Oncology Research Career Development Award (CORP). Positions are available for July 2008 and July 2009. If you are interested in applying, please contact Margy Weinberg (margy.weinberg@case.edu or 216-844-5375). Application deadline: August 1, 2008.

Program Directors
Stanton L. Gerson, MD, Director, Case Comprehensive Cancer Center, and
Alvin H. Schmaier, MD, Chief, Division of Hematology/Oncology

Career Development
Junior faculty appointment in medical, surgical, radiation, or pediatric departments at CWRU and UHCMC. Clinical oncology research that is focused on laboratory-based translational research and includes therapeutic clinical research.

Requirements
MD with clinical training in an oncologic discipline. May be completing a residency and/or fellowship, depending on discipline. Interest and training in clinical trials and/or laboratory-based research. Intent to focus on translational research leading to a clinical trial. Willingness to participate in didactic training in clinical and translational research, to publish and author clinical trials. Minimum two-year commitment required.

Mentoring Faculty
Mentoring provided by nationally recognized basic, clinical, and translational faculty at CWRU and UHCMC.

Resources
The Case CCC has 9 multidisciplinary programs and 17 shared resources that promote focused cancer research and provide unique training opportunities.

Salaries and Research Seed Funds
Salary support at $75,000 for 75% effort plus generous annual research seed money provided through NCI-funded K12 CORP Award. Additional salary for 25% effort provided for clinical responsibilities.

MESSAGE FROM CWRU OFFICE OF GOVERNMENT & COMMUNITY RELATIONS –FY2009 Third Frontier Program

FY2009 Third Frontier program funding announcements (RFPs) are expected to begin being issued in late July or early August. In our effort to improve internal coordination and identification of project proposals that support and complement the University R&D strengths and match Third Frontier goals and outcomes, to be more proactive in interactions with the Ohio Department of Development prior to the RFP releases, and with Eric Cottington's position not yet filled, we are testing a new approach to the University process this year.

Jim Pae in the Office of Research and Tech Management has agreed to serve as the point person for Third Frontier proposals until Eric's successor is on board. We are providing a summary of funding opportunities for FY2009 with brief descriptions of the purpose & outcomes of each program, total funding available for the programs, and expected timelines for each program RFP. Our experience has been that occasionally these time-lines can be delayed, but generally, the delay is no longer than 2 weeks. Consider the dates 95 percent firm.

Note that there will NOT be a call for Wright Centers of Innovation or Ohio Research Scholars in FY2009.

We are requesting that faculty who are interested in pursuing these funding opportunities provide general information about their proposal ideas to Jim Pae by July 2. They do not need to be elaborate and should include the following: Faculty member name and contact information; Name of Third Frontier program (for example, Biomedical Research and Commercialization Program); Title or concept for proposal; and Brief description of proposal (max. one paragraph ). Please submit all materials to Jim Pae james.pae@case.edu by July 2.

MARK YOUR CALENDARS– Cancer Health Disparities Summit

July 14-16
Bethesda North Marriott Hotel and Conference Center
Bethesda, MD

The National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities (CRCHD) is pleased to present the Cancer Health Disparities Summit 2008, July 14–16, at the Bethesda North Marriott Hotel and Conference Center, Bethesda, Maryland. The overall theme for this year's Summit is Eliminating Cancer Health Disparities Through Science, Training, and Community. The Cancer Health Disparities 2008 will highlight the science of the programs and grantees funded through the CRCHD.

For more information, please click here.

MARK YOUR CALENDARS– AACR Centennial Conference

July 20-23
Hyatt Regency Monterey
Monterey, California

The AACR Centennial Conference on Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine is the second in the AACR Centennial Conference series on Translational Cancer Medicine and the first to be held in the United States. Translational research is a key programmatic priority of the AACR, and this meeting will showcase the latest scientific discoveries from the laboratory and their clinical applications.

For more information, please click here.

MARK YOUR CALENDARS– Cancer Immunology and Immunotherapy: Realizing the Promise

September 11-12
National Institutes of Health
Bethesda, MD

The Center for Cancer Research (CCR) at the National Cancer Institute will be hosting a two-day, national symposium entitled Cancer Immunology and Immunotherapy: Realizing the Promise. This meeting will host leaders in the field of cancer immunology and immunotherapy, include recent advances in both translational and clinical research, and should provide an exciting forum for discussion and debate on promising immunologic approaches to prevent and treat cancer.

Registration is free, but seating is limited so be sure to register early! Abstracts are being accepted for the poster session. Deadline for abstract submission is July 15.

For more information, please click here.

PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES

DOD OCRP Consortium Development Award
Pre-Application Deadline: June 25

DOD PCRP Laboratory-Clinical Transition Award: Stage 1
LOI Deadline: June 30

DOD PRMRP Investigator-Initiated Research Award
Proposal Deadline: July 2

DOD PRMRP Investigator-Initiated Research Award (Specific appropriation for bone marrow failure disorder research)
Proposal Deadline: July 2

DOD PRMRP Translational Research Award
Proposal Deadline: July 2

DOD PRMRP Advanced Technology/Therapeutic Development Award
Proposal Deadline: July 2

DOD PRMRP Clinical Trial Award
Proposal Deadline: July 2

DOD OCRP Consortium Development Award
Proposal Deadline: July 9

Breast Cancer Research Foundation- AACR Grant for Translational Breast Cancer Research
Proposal Deadline: July 9

Komen-AACR Outstanding Investigator Award for Breast Cancer Research
Deadline: July 10

Cleveland Clinical and Translational Sciences Collaborative (CTSC)
Deadline: July 15

Susan G. Komen for the Cure: Career Catalyst in Disparities Research
Full Application Deadline: July 31

Susan G. Komen for the Cure: Post-Baccalaureate Training in Disparities Research
Full Application Deadline: July 31

Doris Duke CSDA Bridge Grant
Deadline: September 1

Mesothelioma Applied Research Foundation
Deadline: September 15

NIH Bulletin – Notices and Funding Opportunities

Improving Effectiveness of Smoking Cessation Interventions and Programs in Low Income Adult Populations (R01)(RFA-CA-08-022)

Improving Effectiveness of Smoking Cessation Interventions and Programs in Low Income Adult Populations (R21) (RFA-CA-08-023)